JUL 21, 2018 11:22 AM PDT

Designer Cells Sense & Destroy MRSA

WRITTEN BY: Carmen Leitch

Staphylococcus aureus is a bacterium that causes many illnesses; it’s thought to lead to over 11 million visits to the doctor and the emergency room every year in the United States alone. Researchers at ETH Zurich have aimed to create a therapeutic that can treat serious infections with this pathogen. They engineered a cell that can sense the bacterium and activate a synthetic gene circuit, producing a protein that fights the deadly illness. Rather than using a drug, these designer cells can time the right dose of a protein to cure an infection. The research has been reported in Cell and is outlined by the researchers in the following video.

S. aureus can cause a wide range of symptoms, from relatively minor skin infections to life-threatening conditions like pneumonia, meningitis, and sepsis. As with many other infectious pathogens, the rate of resistance to antibiotics is rising in this bacterium, and it is becoming harder to treat in what is known as methicillin-resistant S. aureus, known as MRSA. The number of deaths caused by MRSA now exceeds those caused by influenza, hepatitis, and HIV/AIDS combined. 

This work is aiming to create new therapeutic strategies for this dangerous disease, especially in the case of bacterial infections on medical implants. S. aureus is a leading cause of implant-associated infections (IAIs); they can form biofilms, which are bacterial communities that are tough and very hard to remove. In some cases, these implants have to be taken out of patients because of S. aureus growth, a severe and costly complication.

scanning electron micrograph (SEM) depicts a grouping of methicillin resistant Staphylococcus aureus (MRSA) bacteria.  / Credit: CDC

The innate immune response each of us is equipped with can detect S. aureus infections and is able to launch a series of signals that results in an immune system attack on the invading pathogen. S. aureus has been around for a long time, however, and has developed a range of tactics for evading that immune response. 

In this research, a gene circuit is employed inside a synthetic cell to sense the pathogen and then express a protein like one used by our immune system; it can kill bacteria, even staphylococcal species. The researchers show that this designer system can be used in both rodent and human cells to create a way to detect and eliminate staphylococcal bacteria. Treatment options for serious staph infections are very limited, and this work shows that the synthetic gene network may be a new option. It was able to prevent MRSA from forming biofilms and cured an acute MRSA infection in a model.

Source: Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
A 'Molecular Clock' for Determining a Child's Age
This tool can aid in the diagnosis of developmental disorders, including autism spectrum disorder....
NOV 21, 2019
Cancer
NOV 21, 2019
Altered DNA methylation controls genes in cancer
New research published in the journal Genome Biology provide new information on genomic structural variation via DNA methylation and its connection to gene...
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Gates Foundation and NIH Pledge $200 Million for Gene Therapies in Africa
Over the next four years, the National Institutes of Health and the Bill and Melinda Gates Foundation plan to each invest $100 million towards the developm...
NOV 21, 2019
Microbiology
NOV 21, 2019
Probiotics Linked to Bloodstream Infections in ICU Patients
Probiotics, which are live microbes, are intended to improve human health, and they are sometimes given to intensive care unit patients of all ages....
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Don't Like Vegetables? It Could be Genetic
Don’t like eating vegetables? Researchers from the University of Kentucky (UKY) have found that the reason why may be genetic.  Humans carry two...
Loading Comments...